Literature DB >> 9616740

Hereditary predisposition to cancer.

A G Knudson1.   

Abstract

Both hereditary and environmental factors influence the risk of cancer. Four risk categories, or oncodemes, can exist for a particular kind of cancer, depending upon the presence of neither, one, or both factors: (1) spontaneous, or background; (2) hereditary; (3) environmental; (4) interactive. In the second, mutation imparts a high relative risk, but a generally low attributable risk; in the fourth, the opposite obtains. The second oncodeme contains genes that are also important for the non-hereditary forms of the same cancer. Probably all forms of cancer exist in a dominantly heritable form. Most of the genes are tumor suppressors, although a few are oncogenes or DNA repair genes. The mutations are in most, if not all cases, maintained in a population by an equilibrium between mutation and selection. Most of the cloned genes are expressed widely among tissues, yet there is typically some tumor specificity. Somatic mutations in second alleles at the relevant loci are necessary, but generally not sufficient for carcinogenesis, although they, in some instances, lead to the formation of benign precursor lesions. Further events are necessary for carcinogenesis. This is particularly true for carcinomas. The benign lesions appear to involve an increase in number of long-lived cells that can accumulate other mutations. For some tumors, physiologic events, such as tissue growth at puberty or proliferation of embryonic stem cells, may produce this effect. Mutations of DNA mismatch repair genes underscore the effect that changes in somatic mutation rates can have, especially in the risk for multi-event carcinomas. Conversely, these are the tumors that offer the greatest opportunity for prevention.

Entities:  

Mesh:

Year:  1997        PMID: 9616740     DOI: 10.1111/j.1749-6632.1997.tb48593.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  11 in total

Review 1.  Gonadoblastoma, testicular and prostate cancers, and the TSPY gene.

Authors:  Y F Lau
Journal:  Am J Hum Genet       Date:  1999-04       Impact factor: 11.025

2.  The sno gene, which encodes a component of the histone deacetylase complex, acts as a tumor suppressor in mice.

Authors:  T Shinagawa; H D Dong; M Xu; T Maekawa; S Ishii
Journal:  EMBO J       Date:  2000-05-15       Impact factor: 11.598

3.  Mutator phenotypes of yeast strains heterozygous for mutations in the MSH2 gene.

Authors:  K Drotschmann; A B Clark; H T Tran; M A Resnick; D A Gordenin; T A Kunkel
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-16       Impact factor: 11.205

4.  Genotyping possible polymorphic variants of human mismatch repair genes in healthy Korean individuals and sporadic colorectal cancer patients.

Authors:  Jin C Kim; Seon A Roh; Kum H Koo; In H Ka; Hee C Kim; Chang S Yu; Kang H Lee; Jung S Kim; Han I Lee; Walter F Bodmer
Journal:  Fam Cancer       Date:  2004       Impact factor: 2.375

Review 5.  Epigenetic alterations in head and neck cancer: prevalence, clinical significance, and implications.

Authors:  Chun-Yang Fan
Journal:  Curr Oncol Rep       Date:  2004-03       Impact factor: 5.075

6.  DNA repair and cancer in colon and rectum: Novel players in genetic susceptibility.

Authors:  Barbara Pardini; Alda Corrado; Elisa Paolicchi; Giovanni Cugliari; Sonja I Berndt; Stephane Bezieau; Stephanie A Bien; Hermann Brenner; Bette J Caan; Peter T Campbell; Graham Casey; Andrew T Chan; Jenny Chang-Claude; Michelle Cotterchio; Manish Gala; Steven J Gallinger; Robert W Haile; Tabitha A Harrison; Richard B Hayes; Michael Hoffmeister; John L Hopper; Li Hsu; Jeroen Huyghe; Mark A Jenkins; Loic Le Marchand; Yi Lin; Noralane M Lindor; Hongmei Nan; Polly A Newcomb; Shuji Ogino; John D Potter; Robert E Schoen; Martha L Slattery; Emily White; Ludmila Vodickova; Veronika Vymetalkova; Pavel Vodicka; Federica Gemignani; Ulrike Peters; Alessio Naccarati; Stefano Landi
Journal:  Int J Cancer       Date:  2019-07-04       Impact factor: 7.316

Review 7.  Imprinted genes as potential genetic and epigenetic toxicologic targets.

Authors:  S K Murphy; R L Jirtle
Journal:  Environ Health Perspect       Date:  2000-03       Impact factor: 9.031

8.  Association between MLH1 -93G>a polymorphism and risk of colorectal cancer.

Authors:  Ting Wang; Yang Liu; Li Sima; Liang Shi; Zhaoming Wang; Chunhui Ni; Zhengdong Zhang; Meilin Wang
Journal:  PLoS One       Date:  2012-11-30       Impact factor: 3.240

Review 9.  Molecular models for the tissue specificity of DNA mismatch repair-deficient carcinogenesis.

Authors:  Elizabeth C Chao; Steven M Lipkin
Journal:  Nucleic Acids Res       Date:  2006-02-06       Impact factor: 16.971

10.  On evolutionary origin of cancer.

Authors:  Anatoly V Lichtenstein
Journal:  Cancer Cell Int       Date:  2005-03-02       Impact factor: 5.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.